Belladonna and Opium Suppositories CII
Generic Name and Formulations:
Belladonna extract (powdered), opium (powdered); 16.2mg/30mg, 16.2mg/60mg.
Indications for Belladonna and Opium Suppositories:
Moderate to severe pain associated with ureteral spasms.
1 supp rectally once or twice daily; max 4 doses/day.
Glaucoma. Severe hepatic or renal disease. Asthma. Narcotic idiosyncrasies. Respiratory depression. Convulsive disorders. Acute alcoholism. Delirium tremens. Premature labor.
Idiosyncrasies to atropine and related drugs. Cardiac disease. Incipient glaucoma. GI or GU obstruction. Increased intracranial pressure. Toxic psychosis. Myxedema. Drug abusers. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.
Antispasmodic + opioid.
CNS effects potentiated with alcohol, other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics. Potentiated by anticholinergics.
Drowsiness, anticholinergic effects (eg, dry mouth, urinary retention, dizziness, blurred vision, constipation), photophobia, tachycardia, GI upset, pruritus, urticaria.
Formerly known under the brand name B&O Supprettes 15A, B&O Supprettes 16A.
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients
- Changes in Renal Cell Carcinoma Pathologic Staging and Histologic Grading
- Nocturia, Overactive Bladder Improved With PTNS
- Many Americans Unaware of Promise of Personalized Medicine
- Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk
- VDRAs Do Not Lower Cardiovascular Event Risk in HD
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)